Loss of the deubiquitinase OTULIN promotes hepatocellular carcinoma (HCC) in an mTOR-dependent manner.

TitleLoss of the deubiquitinase OTULIN promotes hepatocellular carcinoma (HCC) in an mTOR-dependent manner.
Publication TypeJournal Article
Year of Publication2020
AuthorsMarzio A, Pagano M
JournalCell Death Differ
Volume27
Issue5
Pagination1455-1456
Date Published2020 05
ISSN1476-5403
KeywordsCarcinoma, Hepatocellular, Cell Death, Deubiquitinating Enzymes, Fibrosis, Humans, Inflammation, Liver Neoplasms, TOR Serine-Threonine Kinases
DOI10.1038/s41418-020-0531-2
Alternate JournalCell Death Differ
PubMed ID32225171
PubMed Central IDPMC7206064
Grant ListR01 CA076584 / CA / NCI NIH HHS / United States
Related Faculty: 
Antonio Marzio, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700